Prescription pattern of treatment in Mexican patients with Huntington’s Disease.
Objective: To describe the prescription pattern for the treatment of HD in a sample of Mexican patients from a tertiary referral center. Background: Huntington’s disease…The neural correlates of apathy in premanifest and manifest Huntington’s disease: A cross-sectional multimodal imaging study
Objective: To delineate the brain correlates of apathy severity by means of glucose metabolism (18-FDG PET), grey-matter (GM) and white-matter (WM; FA-DTI) changes and relations…Prevalence of substance abuse in Huntington´s disease patients and its relationship with neuropsychiatric symptoms
Objective: To describe the prevalence of substance abuse and its relationship with neuropsychiatric features in Huntington’s disease (HD). Background: Substance abuse is not well established…Screening of cognitive impairment in Huntington’s disease with the Parkinson’s Disease – Cognitive Rating Scale (PD-CRS)
Objective: To explore the psychometric properties of the PD-CRS as compared to two commonly used measures (the MMSE and the UHDRS Cognitive score) for detecting…Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease
Objective: Identify the Evidence based Physicaltherapy available for HD and provide recommendations to physicians Background: In Huntington’s Disease (HD) Chorea is usually presented in any phase…Predictors for psychosis in Huntington’s disease: preliminary analysis of the Enroll-HD database.
Objective: To evaluate predictors for psychosis in HD. Background: Behavioral problems are present across all stages of HD, even preceding the development of the motor…Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey
Objective: To better understand the causes of acute illness and its consequences for subsequent inpatient care in patients with Huntington’s Disease (HD). Background: HD is…Examining central cognitive processing speed as an early marker of Huntington’s disease (HD) onset
Objective: To examine central processing speed as an early marker of Huntington’s disease (HD) onset using the Computerized Test of Information Processing (CTiP). Background: The CTiP,…Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes
Objective: To better understand the relationship between Huntington’s Disease and depression. Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States…Salivary biomarkers for Huntington’s disease (HD)
Objective: The objective of the current study was to assess the potential for saliva to serve as a biospecimen for accessible biomarkers for Huntington’s disease…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.